Amundi
COLL icon

Amundi’s Collegium Pharmaceutical COLL Stock Holding History

Amundi’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$850K Buy
23,492
+15,336
+188% +$524K ﹤0.01% 1445
2026
Q1 		$270K Buy
+8,156
New +$345K ﹤0.01% 1783
2025
Q4 		– Sell
-185,524
Closed -$6.28M – 1850
2025
Q3 		$6.28M Buy
+185,524
New +$6.45M ﹤0.01% 925
2025
Q2 		– Sell
-62,592
Closed -$1.82M – 1775
2025
Q1 		$1.82M Buy
62,592
+47,024
+302% +$1.44M ﹤0.01% 1177
2024
Q4 		$519K Buy
15,568
+10,168
+188% +$336K ﹤0.01% 1560
2024
Q3 		$205K Buy
5,400
+504
+10% +$18K ﹤0.01% 1656
2024
Q2 		$158K Buy
+4,896
New +$170K ﹤0.01% 1622
2023
Q2 		– Sell
-4,586
Closed -$108K – 2048
2023
Q1 		$108K Buy
+4,586
New +$122K ﹤0.01% 1720

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Amundi's COLL Position: Q2 2026 in Review

Amundi increased its Collegium Pharmaceutical (COLL) stake by 188% in Q2 2026, buying an estimated $524K and bringing the position to 23,492 shares worth $850K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

Amundi first reported a position in COLL in Q1 2023 and has held it in 8 quarters since. The position peaked at $6.28M in Q3 2025. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Amundi held 23,492 shares of Collegium Pharmaceutical worth $850K as of Q2 2026.
  • Amundi bought 15,336 Collegium Pharmaceutical shares in Q2 2026, an estimated $524K.
  • Collegium Pharmaceutical made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1445 holding.
  • Amundi first reported a position in Collegium Pharmaceutical in Q1 2023 and has held it in 8 quarters since.
  • Amundi's Collegium Pharmaceutical position peaked at $6.28M in Q3 2025.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.